Related references
Note: Only part of the references are listed.Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
Yuxuan Song et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer
Yuanyuan Ma et al.
CELL DEATH & DISEASE (2021)
Lysosomes and Cancer Progression: A Malignant Liaison
Eda R. Machado et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance
Sunil K. Joshi et al.
CANCER CELL (2021)
High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis
Dawei Zhu et al.
ONCOGENESIS (2021)
Cytosolic DNA sensing by cGAS: regulation, function, and human diseases
Le Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Xi Chen et al.
NATURE REVIEWS CANCER (2021)
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition
Wook Jin
CELLS (2020)
Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines
Jiarong Zhou et al.
CANCER MEDICINE (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model
Kyeongsoo Jeong et al.
LAB ON A CHIP (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance
Lorenza Sisinni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
In-Hye Ham et al.
MOLECULAR CANCER (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression
Liang-Zhi Wen et al.
CANCER RESEARCH (2018)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Emerging roles and mechanisms of FOXC2 in cancer
Teng Wang et al.
CLINICA CHIMICA ACTA (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
The multisystemic functions of FOXD1 in development and disease
Paula Quintero-Ronderos et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Hydrogel-incorporating unit in a well: 3D cell culture for high-throughput analysis
Yeong Jun Yu et al.
LAB ON A CHIP (2018)
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
Clarissa Gerhauser et al.
CANCER CELL (2018)
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Yun-Gil Roh et al.
BMB REPORTS (2018)
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler et al.
EUROPEAN UROLOGY (2017)
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
T. Avril et al.
ONCOGENESIS (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Molecular biomarkers to predict response to neoadjuvant chemotherapy CrossMark for bladder cancer
Consuelo Buttigliero et al.
CANCER TREATMENT REVIEWS (2017)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours
Peter A. Humphrey et al.
EUROPEAN UROLOGY (2016)
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du et al.
MOLECULES (2016)
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Bishoy M. Faltas et al.
NATURE GENETICS (2016)
MAP4K4: an emerging therapeutic target in cancer
Xuan Gao et al.
CELL AND BIOSCIENCE (2016)
FOXA1, GATA3 and PPARγ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
Joshua I. Warrick et al.
SCIENTIFIC REPORTS (2016)
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
Peijing Zhang et al.
CELL CYCLE (2015)
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer
Se-Ra Lee et al.
CLINICAL CANCER RESEARCH (2015)
Epithelial-mesenchymal transition and drug resistance in breast cancer
Jing Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Promising molecular mechanisms responsible for gemcitabine resistance in cancer
Yanfei Jia et al.
GENES & DISEASES (2015)
The Emerging Role of ABL Kinases in Solid Tumors
Jun Wang et al.
TRENDS IN CANCER (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
New Function of Type I IFN: Induction of Autophagy
Hana Schmeisser et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Bladder cancers arise from distinct urothelial sub-populations
Jason Van Batavia et al.
NATURE CELL BIOLOGY (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Pathview: an R/Bioconductor package for pathway-based data integration and visualization
Weijun Luo et al.
BIOINFORMATICS (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma-Neoadjuvant and Adjuvant Settings
Cora N. Sternberg et al.
EUROPEAN UROLOGY (2013)
Proliferation Enhanced By NGF-NTRK1 Signaling Makes Pancreatic Cancer Cells More Sensitive To 2DG-Induced Apoptosis
Yao Cheng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene
Maria Tarragona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis
Jikyoung Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Surface-Treatment-Induced Three-Dimensional Capillary Morphogenesis in a Microfluidic Platform
Seok Chung et al.
ADVANCED MATERIALS (2009)
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
Y. Nakano et al.
BRITISH JOURNAL OF CANCER (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Prognosis of muscle-invasive bladder cancer: Difference between primary and progressive tumours and implications for therapy
BP Schrier et al.
EUROPEAN UROLOGY (2004)
Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
VL Damaraju et al.
ONCOGENE (2003)